Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7249 p680
17 May 2003

This page
Reprint
Photocopy

   

PDF* 62K

Letters

  The industry
  Medicines management
  The Register
  CPD
  Supplements


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Supplements

Educate the public by making supplements P medicines

From Mr P. M. W. Clarke, MRPharmS

For years, government advisers have been telling us that vitamins and food supplements are harmless enough to be treated as normal items of commerce and sold by anyone willing to stock them. At last they are now saying that they may do more harm than good.

The fact that the products are not restricted to professional supervision means that members of the public, understandably, do not take precautions, and probably do not read the dosage leaflets .

Compared with most of the European Community governments across the channel, where health in the public domain is considered paramount, we in the United Kingdom take a laid-back, even careless, attitude, eg, mad cow disease, foot and mouth disease, and failure to get all human over-the-counter medicines regarded as a special category.

Many years ago, when I was in charge of a pharmacy, I
insisted that requests for an over-the-counter product, Entero-vioform, were referred to me so that I could tell the customer about reports of a serious ophthalmic side effect, subacute myelo-optico-neuropathy (SMON). A couple of years later the product was banned. I did the same thing with a type of vitamin supplement, high dose vitamin A in Sylvasun tan tablets. These were banned too, eventually.

The way to educate the public about potent medicinal products, or at least make them aware that they are not trivial, is by making them pharmacy medicines and by not allowing the manufacturers and supermarkets, for sheer commercial reasons, to get more and more medicines listed as “Grocery Store Lines”.


P. M. W. Clarke
Saumur, France

 

Send your letter to The Editor

Previous Topic (CPD)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal